Direct medical cost of oropharyngeal cancer among patients insured by Medicaid in Texas
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Oral Oncology
- Vol. 96, 21-26
Abstract
No abstract availableKeywords
Funding Information
- Cancer Prevention and Research Institute of Texas (RP170259)
- Cancer Prevention and Research Institute of Texas
- Lyda Hill Foundation
- University of Texas MD Anderson Cancer Center
This publication has 25 references indexed in Scilit:
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage LevelsJNCI: Journal of the National Cancer Institute, 2013
- Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory PapillomatosisVaccine, 2012
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Impact of vaccinating boys and men against HPV in the United StatesVaccine, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Medical and Dental Care Utilization and Expenditures Under Medicaid and Private Health InsuranceMedical Care Research and Review, 2009
- The economic burden of noncervical human papillomavirus disease in the United StatesAmerican Journal of Obstetrics and Gynecology, 2008
- Quality of life after surgical treatment for oral and oropharyngeal cancer: A prospective longitudinal assessment of patients reconstructed by a microvascular flapOral Oncology, 2007
- Cost of care for early‐ and late‐stage oral and pharyngeal cancer in the California Medicaid populationHead & Neck, 2007
- A Psychiatric Patient Classification SystemMedical Care, 1989